Changing Patterns of Causation and the Use of Transplantation in the United Kingdom

ABSTRACT

Acute liver failure (ALF) is a rare condition in the United Kingdom. Comprehensive supportive intensive care of extra-hepatic organ failure and the early recognition of and use of transplantation for those who will not survive form the cornerstone of its management. Over the last 30 years there has been a reduction in the proportion of cases resulting from viral and seronegative hepatitis, and a progressive rise in those resulting from severe acetaminophen-induced hepatotoxicity. The latter cases mostly result from deliberate self-poisoning and formed the major cause of ALF hospital admissions and indication for emergency liver transplantation. The increasing misuse of acetaminophen has paralleled a rise in sales and greater availability of the drug. Introduction of legislation to restrict sales of acetaminophen has been followed by a fall in hospital admissions resulting from self-poisoning, a 20% reduction in deaths, and a 50% fall in the number of patients undergoing emergency liver transplantation. The reduction in acetaminophen-related ALF has been paralleled by an increase in the number of transplants performed in ALF of nonacetaminophen etiologies.

KEYWORDS

Acute liver failure - acetaminophen - self-poisoning - transplantation - hepatotoxicity

REFERENCES

• 1 Mortality Statistics: cause.  National Statistics. London: The Stationery Office; 1999
• 2 Williams R. Classification, etiology, and considerations of outcome in acute liver failure.  Semin Liver Dis . 1996;  16 343-348
• 3 O'Grady J. Acute liver failure. In: O'Grady J, Lake J, Howdle P, eds. Comprehensive Clinical Hepatology, 1st ed London: Mosby 2000 : 30.1-30.20
• 4 Hartley P, Petruckvitch A, Reeves B. et al . The national liver transplantation audit: an overview of patients presenting for liver transplantation from 1994 to 1998.  Br J Surg . 2001;  88 52-58
• 5 Statistics prepared by UK Transplant from the National Transplant Database maintained on behalf of transplant services in the UK and Republic of Ireland. October 2002
• 6 Dhiman R, Seth A, Jain S. et al . Prognostic evaluation of early indicators in fulminat hepatic failure by multivariate analysis.  Dig Dis Sci . 1998;  43 1311-1316
• 7 Ellis A, Rhodes A, Jackson N. et al . Acute liver failure (ALF) in a specialist intensive care unit; a 7 year experience.  Crit Care . 1998;  2(Suppl 1) P150
• 8 Ostapowicz G, Fontana R, Sciodt F. et al . Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.  Ann Intern Med . 2002;  137 947-954
• 9 Trigo P, Lendoire J, Braslavsky G. et al . Etiology and outcome of 83 patients with fulminant hepatic failure in adults. Experience of an Argentinian liver transplant unit.  Hepatology . 2001;  34 657A
• 10 O'Grady J, Schalm S, Williams R. Acute liver failure; redefining the syndromes.  Lancet . 1993;  342 273-275
• 11 O'Grady J, Alexander G, Hayllar K, Williams R. Early indicators of prognosis in fulminant hepatic failure.  Gastroenterology . 1989;  97 439-445
• 12 Anand A, Nightingale P, Neuberger J. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Kings's criteria.  J Hepatol . 1997;  26 62-68
• 13 Bernal W, Wendon J, Rela M. et al . Use and outcome of liver transplantation in acetaminophen induced acute liver failure.  Hepatology . 1998;  27 1050-1055
• 14 O'Grady J, Wendon J, Tan K. et al . Liver transplantation after paracetomol overdose.  BMJ . 1991;  303 221-223
• 15 Mitchell I, Bihari D, Chang R. et al . Earlier identification of patients at risk from acetaminophen induced acute liver failure.  Crit Care Med . 1998;  26 279-284
• 16 Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure.  Lancet . 2002;  359 558-563
• 17 Pereira L M, Langley P G, Hayllar K M. et al . Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.  Gut . 1992;  33 98-102
• 18 Izumi S, Langley P G, Wendon J. et al . Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure.  Hepatology . 1996;  23 1507-1511
• 19 Sizer E, Bernal W, Wendon J. Acute liver failure in the intensive care unit. In: Vincent J, ed. 2003 Yearbook of Intensive Care and Emergency Medicine Berlin: Springer 2003
• 20 Rivers E, Nguyen B, Havstad S. et al . Goal-directed therapy for severe sepsis and septic shock.  N Engl J Med . 2001;  345 1368-1377
• 21 Makin A, Wendon J, Williams R. A seven year experience of severe acetominophen-induced hepatotoxicity (1987-1993).  Gastroenterology . 1995;  109 1907-1916
• 22 Bihari D, Gimson A, Lindridge J, Williams R. Lactic acidosis in fulminant hepatic failure: some aspects of pathogenesis and prognosis.  J Hepatol . 1985;  1 405-416
• 23 Harry R, Ausinger G, Wendon J. Clinical importance of adrenal insufficiency in acute hepatic dysfunction.  Hepatology . 2002;  36 395-402
• 24 Annane D, Sebille V, Charpentier C. et al . Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.  JAMA . 2002;  288 862-871
• 25 Davenport A, Will E J, Davidson A M. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure.  Crit Care Med . 1993;  21 328-338
• 26 Davenport A, Will E J, Davison A M. et al . Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy.  Nephron . 1989;  53 142-146
• 27 Forni L, Hilton P. Current concepts: continuous hemofiltration in the treatment of acute renal failure.  N Engl J Med . 1997;  336 1303-1309
• 28 Bellomo R, Baldwin I, Ronco C. High volume hemofiltration.  Curr Opin Crit Care . 2000;  6 442-445
• 29 Ronco C, Bellomo R, Homel P. et al . Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomised trial.  Lancet . 2000;  355 26-30
• 30 Ede R, Gimson A, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral odema in fulminant hepatic failure.  J Hepatol . 1986;  2 43-51
• 31 Wendon J A, Harrison P M, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure.  Hepatology . 1994;  19 1407-1413
• 32 Strauss G, Hogh P, Knudsen G. et al . Regional cerebral blood flow during mechanical hyperventilation in patients with fulminant hepatic failure.  Hepatology . 1999;  30 1368-1373
• 33 Cordoba J, Gottstein J, Blei A. Chronic hyponatraemia exacerbates ammonia induced brain edema in rats after portocaval anastamosis.  J Hepatol . 1998;  29 589-594
• 34 Murphy N, Wendon J. Serum sodium is inversely proportional to intracranial pressure in acute liver failure (Abst).  Crit Care . 1999;  3(Suppl 1) 110
• 35 Schell R, Cole D. Cerebral monitoring: jugular venous oximetry.  Anesth Analg . 2000;  90 559-566
• 36 Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infections in acute liver failure.  Semin Liver Dis . 1996;  16 389-402
• 37 Rolando N, Wade J, Davalos M. et al . The systemic inflammatory response in acute liver failure.  Hepatology . 2000;  32 734-739
• 38 O'Grady J. Fulminant hepatitis in patients with chronic liver disease.  J Viral Hepat . 2000;  7(Suppl 1) 9-10
• 39 Sallie R, Silva A E, Purdy M. et al . Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study.  J Hepatol . 1994;  20 580-588
• 40 Jackson N, Ellis A, Rhodes A. et al . Non-paracetamol drug induced acute liver failure in a specialist liver intensive care unit: a seven year experience.  Hepatology . 1998;  28 496A
• 41 Henry J A, Jeffreys K J, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”).  Lancet . 1992;  340 384-387
• 42 Ellis A J, Wendon J A, Portmann B, Williams R. Acute liver damage and ecstasy ingestion.  Gut . 1996;  38 454-458
• 43 Andreu V, Mas A, Bruguera M. et al . Ecstacy: a common cause of severe acute hepatotoxicity.  J Hepatol . 1998;  29 394-397
• 44 Crowcroft N, Walsh B, Davidson K. et al . Guidelines for the control of hepatitis A infection.  Communicable Disease and Public Health . 2001;  4 213-227
• 45 Goldberg D, McMenamin J. The United Kingdom's hepatitis B immunisation strategy-where now?.  Communicable Disease and Public Health . 1998;  1 79-83
• 46 Melnick J. History and epidemiology of hepatitis A virus.  J Infect Dis . 1995;  171(Suppl 1) S2-S8
• 47 Damme P V, Tormans G, Beutels P, Doorslaer E V. Hepatitis B prevention in Europe: a preliminary economic evaluation.  Vaccine . 1995;  13 S54-S57
• 48 Kyrlagkitsis I, Cramp M, Smith H. et al . Acute hepatitis A virus infection: a review of prognostic factors from 25 years experience in a tertiary referral center.  Hepatogastroenterology . 2002;  49 524-528
• 49 Gow P, Mutimer D. Non-A, non-B fulminant hepatic failure.  Arch Intern Med . 2001;  161 1013-1014
• 50 Williams R, Riordan S. Acute liver failure: established and putatative hepatitis viruses and therapeutic implications.  J Gastroenterol Hepatol . 2000;  15 G17-G25
• 51 McCrudden R, O'Connell S, Farrant T. et al . Sporadic acute hepatitis E in the United Kingdom: an underdiagnosed phenomenon?.  Gut . 2000;  46 732-733
• 52 Wilkinson S, Taylor G, Templeton L. et al . Admissions to hospital for deliberate self-harm in England 1995-2000; an analysis of Hospital Episode Statistics.  J Public Health Med . 2002;  24 179-183
• 53 Hawton K, Fagg J, Simkin S. et al . Trends in deliberate self harm in oxford, 1985-1995.  Br J Psychiatry . 1997;  171 556-560
• 54 Shah R, Uren Z, Baker A, Majeed A. Trends in suicide from drug overdose in the elderly in England and Wales 1993-1999.  Int J Geriatr Psychiatry . 2002;  17 416-421
• 55 McLoone P, Crombie I K. Hospitalisation for deliberate self-poisoning in Scotland from 1981 to 1993; trends in rates and types of drugs used.  Br J Psychiatry . 1996;  169 81-85
• 56 Prescott L. Paracetamol overdose. In: Paracetamol (Acetaminophen) a Critical Bibliographic Review London: Taylor and Francis 1996: 401-473
• 57 Makin A J, Williams R. Acetaminophen-induced hepatotoxicity: predisposing factors and treatments.  Adv Intern Med . 1997;  42 453-483
• 58 Deaths related to drug poisoning results for England and Wales, 1993 to 2000. Health Statistic Quarterly 2002; 13:76-82 www.statistics.gov.uk/downloads/theme health/ HSQ13 v4.pdf . 
• 59 Makin A, Williams R. Paracetamol hepatotoxicity and alcohol consumption in deliberate and accidental overdose.  QJM . 2000;  93 341-349
• 60 Townsend E, Hawton K, Harriss L. et al . Substances used in deliberate self poisoning 1985-1997; trend and associations with age, gender, repetition and suicidal intent.  Soc Psychiatry Psychiatric Epidemiol . 2001;  36 228-234
• 61 Gunnell D, Hawton K, Murray V. et al . Use of paracetamol for suicide and non-fatal self poisoning in the UK and France: are restrictions on availability justified?.  J Epidemiol Community Health . 1997;  51 175-179
• 62 Hawton K, Ware C, Mistry H. et al . Why patients choose paracetamol for self poisoning and their knowledge of its dangers.  BMJ . 1995;  310 69-73
• 63 Hawton K, Ware C, Mistry H. et al . Paracetamol self-poisoning. Characteristics, prevention and harm reduction.  Br J Psychiatry . 1996;  168 43-48
• 64 Newson P, Bathgate A, Henderson N. et al . Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland.  Lancet . 2001;  358 1612-1613
• 65 Hawton K, Harriss L, Hodder K. et al . The influence of economic and social environment on deliberate self-harm and suicide: an ecological and person-based study.  Psychol Med . 2001;  31 827-836
• 66 Neeleman J, Wessely S. Drugs taken in fatal and non-fatal self poisoning a study in south London.  Acta Psychiatr Scand . 1997;  95 283-287
• 67 Prescott L. Paracetamol, alcohol and the liver.  Br J Clin Pharmacol . 2000;  49 291-301
• 68 Schmidt L, Dalhoff K, Poulsen H. Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity.  Hepatology . 2002;  35 876-882
• 69 Kuffner E, Dart R, Bogdan G. et al . Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients.  Arch Intern Med . 2001;  161 2247-2252
• 70 Whitcomb D, Block G. Association of acetaminophen hepatotoxicity with fasting and ethanol use.  JAMA . 1994;  272 1845-1850
• 71 Read R B, Tredger J M, Williams R. Analysis of factors responsible for continuing mortality after paracetamol overdose.  Hum Toxicol . 1986;  5 201-206
• 72 Foster T. Dying for a drink.  BMJ . 2001;  323 817-818
• 73 Galanos A, Pieper C, Kussin P. et al . Relationship of body mass index to subsequent mortality among seriously ill hospitalised patients.  Crit Care Med . 1997;  25 1962-1968
• 74 Sheen C, Dillon J, Bateman D. et al . Paracetamol toxicity: epidemiology, prevention and costs to the health-care system.  QJM . 2002;  95 609-619
• 75 Jones A, Hayes P, Proudfoot A. et al . Should methionine be added to every paracetamol tablet?.  BMJ . 1997;  315 301-304
• 76 Gunnell D, Murray V, Hawton K. Use of paracetamol (acetaminophen) for suicide and nonfatal poisoning: worldwide patterns of use and misuse.  Suicide Life Threat Behav . 2000;  30 313-326
• 77 WHO. The world health report 2001. Mental health: new understanding, new hope. Geneva: World Health Organization 2001
• 78 Proudfoot A T, Park J. Changing pattern of drugs used for self-poisoning.  BMJ . 1978;  1 90-93
• 79 Bowles J. Suicide prevention in western Samoa: an example of a suicide prevention program in a developing country. In: Diekstra R, Gulbinat W, Kienhorst I, Leo D, eds. Preventative Strategies on Suicide Leiden: EJ Brill 1995: 173-206
• 80 Oliver R, Hetzel B. An analysis of recent trends in suicide rates in Australia.  Int J Epidemiol . 1973;  2 91-101
• 81 Ott P, Dalhoff K, Hansen P B. et al . Consumption, overdose and death from analgesics during a period of over-the-counter availability of paracetamol in Denmark.  J Int Med . 1990;  227 423-428
• 82 Committee on Safety of Medicines, Medicines Control Agency. Paracetamol and aspirin.  Current Problems in Pharmacovigilance . 1997;  23 9
• 83 Fagan E, Wannan G. Reducing paracetomol overdoses.  BMJ . 1996;  313 1417-1418
• 84 Laffoy M, Byrne G, Scallan E. Paracetamol availability and overdose in Ireland.  Irish Med J . 2001;  94 7
• 85 Thomas M, Jowett N. Restriction has not reduced admissions with self poisoning.  BMJ . 2001;  322 553
• 86 Balit C, Isbister G, Peat J. et al . Paracetamol recall: a natural experiment influencing analgesic poisoning.  Med J Aust . 2002;  176 163-166
• 87 Hawton K, Townsend E, Deeks J. et al . Effects of legislation restricting pack sizes of paracetamol and salycilate poisoning in the United Kingdom; before and after study.  BMJ . 2001;  322 1203-1207
• 88 Prince M, Thomas S, James O, Hudson M. Reduction in incidence of severe paracetamol poisoning.  Lancet . 2000;  355 2047-2048
• 89 Turvill J, Burroughs A, Moore K. Change in occurrence of paracetamol overdose in UK after introduction of blister packs.  Lancet . 2000;  355 2048-2049
• 90 Sheen C, Dillon J, Bateman D. et al . Paracetamol pack size restriction: the impact on paracetamol poisoning and over-the-counter supply of paracetamol, asprin and ibuprofen.  Pharmacoepidemiology and Drug Safety . 2002;  11 329-331
• 91 Spooner J, Harvey J. Paracetamol overdose; Facts not misconceptions.  Pharmaceutical Journal . 1993;  252 706-707
• 92 Robinson D, Smith A, Johnston G. Severity of overdose after restriction of paracetamol availability: retrospective study.  BMJ . 2000;  321 926-927
• 93 Sheen C, Dillon J, Bateman D. et al . The effect on toxicity on reducing the size of available paracetamol pack sizes.  Gut . 2001;  48(Suppl 1) A105
• 94 Poulin C. Prevention of paracetamol poisoning.  Lancet . 2000;  355 2009-2010
• 95 Hill A. The environment and disease: association or causation?.  Proc R Soc Med . 1965;  295-300
• 96 Altman D. Practical Statistics for Medical Research.  London: Chapman and Hall; 1991
• 97 Bond G R, Hite L. Population-based incidence and outcome of acetaminophen poisoning by type of ingestion.  Acad Emerg Med . 1999;  6 1115-1120
• 98 Nourjah P, Willey M. Epidemiology of acetaminophen-related overdose. Department of Health and Human Services, Center for Drug Evaluation and Research, Food and Drug Administration, 2002. www.fda.gov/ohrms/dockets/ac/02/ briefing/3882b1.htm
• 99 Ahmad S. OPDRA safety review: review of acetaminophen poisoning exposures in Toxic Exposure Surveillance System (TESS). Department of Health and Human Services, Center for Drug Evaluation and Research, Food and Drug Administration, 2002. www.fda.gov/ohrms/dockets/ac/02 /briefing/3882b1.htm
• 100 Schiodt F, Atillasoy E, Shakil A. et al . Etiology and prognosis for 295 patients with acute liver failure in the US Liver Transplantation and Surgery .  1999;  5 29-34
• 101 Gyamlani G, Parikh C. Acetaminophen toxicity: suicidal versus accidental.  Critical Care . 2002;  6 155-169
• 102 Prescott L. Therapeutic misadventure with paracetamol: fact or fiction?.  American Journal of Therapeutics . 2000;  7 99-114
• 103 Food and Drug Administration. September 2002.fdaadvisorycommittee.com/FDC/AdvisoryCommittee/Committees/Nonprescription+Drugs/091902 acetaminophen/091902 AcetaminophenR.htm#.